Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pituitary ACTH Hypersecretion × relacorilant × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary ACTH Hypersecretion 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Hypertension 1 Fallopian Tube Neoplasms 1 Diabetes Mellitus, Type 2 1 Cushing Syndrome 1 ACTH Syndrome, Ectopic 1

Interventions

Mifepristone 3 Corlux 3 relacorilant 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03697109 2025-07-16

GRACE

Corcept Therapeutics

Phase 3 Completed

152 enrolled 28 charts

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Pituitary ACTH Hypersecretion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡